Catalyst Wire Dossier Catalyst Wire Dossier

Albinterferon alfa-2b

albinterferon alfa-2b · Novartis Pharmaceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Albinterferon alfa-2b, covering 2011-01-06 to 2011-01-06. Get the full timeline:

Most recent: Clinical Trial Update: Pharmacokinetic/Pharmacodynamic of Albinterferon Alfa-2b in Chronic Hepatitis B, eAg+, Infection Subjects [Phase 1, Phase 2]

See pricing